End-of-life matters in chronic heart failure patients

被引:13
作者
Sobanski, Piotr [1 ,2 ]
Jaarsma, Tiny [3 ]
Krajnik, Malgorzata [4 ]
机构
[1] Hildegard Palliat Ctr Basel, Basel, Switzerland
[2] Univ Basel Hosp, Gynaecol Canc Ctr, CH-4031 Basel, Switzerland
[3] Linkoping Univ, Dept Social & Welf Studies, Linkoping, Sweden
[4] Nicholas Copernicus Univ, Coll Med Bydgoszcz, Dept Palliat Care, Bydgoszcz, Poland
关键词
death and dying; end of life; heart failure; implanted cardiac devices; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ELDERLY-PATIENTS; DEACTIVATION; SURVIVAL; DEATH; MODE; CARE; PREFERENCES; THERAPY; TIME;
D O I
10.1097/SPC.0000000000000094
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose of review Until recently, concepts of care for people with heart failure had rarely included preparation for unavoidable imminent death or caring for the dying. The purpose of this review is to provide an update on current end-of-life issues specific to heart failure patients. Recent findings Mortality in the heart failure population remains high, especially shortly after the first acute heart failure hospitalization. Patients with systolic heart failure die more frequently from progressive heart failure or sudden cardiac death; patients with diastolic heart failure for noncardiovascular reasons and sudden cardiac death. The mode of haemodynamic decline leading to heart failure death can be characterised by low cardiac output (with or without secondary end-organ dysfunction), congestion, or a combination of both. A new model of end-of-life trajectories has been proposed which takes into account influence of comorbidities on the prognosis of heart failure. Advance care planning for patients with implanted cardiac devices has been shown to be unsatisfactory. A recent strategy for managing implantable cardioverter defibrillators in patients approaching death is presented. Summary There is an emerging need to define specific challenges for end-of-life care for approaching death in heart failure patients. More research and education are needed to improve care for dying heart failure patients, including those with implanted cardiac devices.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 28 条
  • [1] Ethical Challenges With Deactivation of Durable Mechanical Circulatory Support at the End of Life: Left Ventricular Assist Devices and Total Artificial Hearts
    不详
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2014, 29 (01) : 3 - 12
  • [2] End-of-life care conversations with heart failure patients: a systematic literature review and narrative synthesis
    Barclay, Stephen
    Momen, Natalie
    Case-Upton, Steve
    Kuhn, Isla
    Smith, Elizabeth
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2011, 61 (582) : e49 - e62
  • [3] Self-care and communication issues at the end of life of recipients of a left-ventricular assist device as destination therapy
    Ben Gal, Tuvia
    Jaarsma, Tiny
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (01) : 29 - 35
  • [4] End-of-life preferences of elderly patients with chronic heart failure
    Brunner-La Rocca, Hans-Peter
    Rickenbacher, Peter
    Muzzarelli, Stefano
    Schindler, Ruth
    Maeder, Micha T.
    Jeker, Urs
    Kiowski, Wolfgang
    Leventhal, Marcia E.
    Pfister, Otmar
    Osswald, Stefan
    Pfisterer, Matthias E.
    Rickli, Hans
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (06) : 752 - 759
  • [5] Incidence and Survival of Hospitalized Acute Decompensated Heart Failure in Four US Communities (from the Atherosclerosis Risk in Communities Study)
    Chang, Patricia P.
    Chambless, Lloyd E.
    Shahar, Eyal
    Bertoni, Alain G.
    Russell, Stuart D.
    Ni, Hanyu
    He, Max
    Mosley, Thomas H.
    Wagenknecht, Lynne E.
    Samdarshi, Tandaw E.
    Wruck, Lisa M.
    Rosamond, Wayne D.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (03) : 504 - 510
  • [6] Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras
    Cubbon, Richard M.
    Gale, Christopher P.
    Kearney, Lorraine C.
    Schechter, Clyde B.
    Brooksby, W. Paul
    Nolan, Jim
    Fox, Keith A. A.
    Rajwani, Adil
    Baig, Wazir
    Groves, David
    Barlow, Pauline
    Fisher, Anthony C.
    Batin, Phillip D.
    Kahn, Matthew B.
    Zaman, Azfar G.
    Shah, Ajay M.
    Byrne, Jon A.
    Lindsay, Steven J.
    Sapsford, Robert J.
    Wheatcroft, Stephen B.
    Witte, Klaus K.
    Kearney, Mark T.
    [J]. CIRCULATION-HEART FAILURE, 2011, 4 (04) : 396 - +
  • [7] Patient Preferences for Deactivation of Implantable Cardioverter-Defibrillators
    Dodson, John A.
    Fried, Terri R.
    Van Ness, Peter H.
    Goldstein, Nathan E.
    Lampert, Rachel
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (05) : 377 - 379
  • [8] Advance Directives in Community Patients With Heart Failure
    Dunlay, Shannon M.
    Swetz, Keith M.
    Mueller, Paul S.
    Roger, Veronique L.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (03): : 283 - 289
  • [9] Living and dying with heart failure: its time to talk
    Dunlay, Shannon M.
    Roger, Veronique L.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (06) : 689 - 691
  • [10] Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
    Froehlich, Georg M.
    Holzmeister, Johannes
    Huebler, Michael
    Huebler, Samira
    Wolfrum, Mathias
    Enseleit, Frank
    Seifert, Burkhardt
    Huerlimann, David
    Lehmkuhl, Hans B.
    Noll, Georg
    Steffe, Jan
    Falk, Volkmar
    Luescher, Thomas F.
    Hetzer, Roland
    Ruschitzka, Frank
    [J]. HEART, 2013, 99 (16) : 1158 - 1165